↓ Skip to main content

Evaluation of ostarine as a selective androgen receptor modulator in a rat model of postmenopausal osteoporosis

Overview of attention for article published in Journal of Bone and Mineral Metabolism, May 2018
Altmetric Badge

Mentioned by

twitter
2 X users
video
1 YouTube creator

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
44 Mendeley
Title
Evaluation of ostarine as a selective androgen receptor modulator in a rat model of postmenopausal osteoporosis
Published in
Journal of Bone and Mineral Metabolism, May 2018
DOI 10.1007/s00774-018-0929-9
Pubmed ID
Authors

D. B. Hoffmann, M. Komrakova, S. Pflug, M. von Oertzen, D. Saul, L. Weiser, T. A. Walde, M. Wassmann, A. F. Schilling, W. Lehmann, S. Sehmisch

Abstract

Selective androgen receptor modulators (SARMs) have shown beneficial effects on muscle wasting, general physical function and bone properties in male mammals. However, data on the effects of SARMs in postmenopausal osteoporotic bone are scarce. We evaluated the effects of the SARM drug ostarine on postmenopausal osteoporotic bone in a rat osteoporosis model. Ovariectomy was performed on 46 of 56 3-month-old female Sprague-Dawley rats. Eight weeks after ovariectomy, ostarine was orally administered daily for 5 weeks in dosages of 0.04 (low, OVX + Ost. 0.04), 0.4 (intermediate, OVX + Ost. 0.4), and 4 mg/kg (high, OVX + Ost. 4) body weight. Another ovariectomized group received no ostarine. Lumbar vertebrae and femora were removed for biomechanical, gene expression, ashing, and computer tomography analyses. Low dose showed no effects. The effects of intermediate and high doses were comparable overall. Improvements were mainly seen in structural properties such as bone mineral density and bone volume density. However, the effects in femora were superior to effects in vertebrae. Ostarine treatment for 5 weeks did not improve significantly biomechanical properties. mRNA expression of the receptor activator of NF-κB ligand decreased after treatment, and uterine weight increased. Serum levels of phosphorus increased following ostarine treatment in intermediate and high-dose groups. Short-term treatment of osteoporotic bone with ostarine leads to improvement of several microstructural bone indices. While we did not observe changes in biomechanics, it is conceivable that longer treatment may also improve biomechanical properties. Further studies are needed to characterize longer time effects and side effects of ostarine in osteoporosis.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 44 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 20%
Student > Bachelor 6 14%
Student > Ph. D. Student 5 11%
Researcher 4 9%
Student > Doctoral Student 2 5%
Other 6 14%
Unknown 12 27%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 5 11%
Pharmacology, Toxicology and Pharmaceutical Science 5 11%
Medicine and Dentistry 5 11%
Nursing and Health Professions 4 9%
Business, Management and Accounting 2 5%
Other 9 20%
Unknown 14 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 September 2018.
All research outputs
#16,061,913
of 23,842,189 outputs
Outputs from Journal of Bone and Mineral Metabolism
#367
of 787 outputs
Outputs of similar age
#212,539
of 332,173 outputs
Outputs of similar age from Journal of Bone and Mineral Metabolism
#4
of 7 outputs
Altmetric has tracked 23,842,189 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 787 research outputs from this source. They receive a mean Attention Score of 2.7. This one is in the 44th percentile – i.e., 44% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 332,173 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.